Sign In
Buy TYME
$0.311
+0 (+0%)
At Close: Jan 27, 2023
Top Biotech Penny Stocks to Watch in June 2021? Here's 4 For Your List
02:38pm, Thursday, 27'th May 2021
Biotech penny stocks are pushing up; here's 4 for your watchlist The post Top Biotech Penny Stocks to Watch in June 2021? Here's 4 For Your List appeared first on Penny Stocks to Buy, Picks, News and
Best Penny Stocks in 2021 So Far? Here's 4 You Should Check Out
05:16pm, Wednesday, 26'th May 2021
These penny stocks are pushing up, should you add them to your watchlist? The post Best Penny Stocks in 2021 So Far?
TYME Technologies, Inc. to Host Conference Call and Live Video Webcast on Thursday, June 10th at 5:00 PM ET
08:05am, Wednesday, 26'th May 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “TYME”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTstm), t
3 Penny Stocks To Watch Under $2 Making Big Moves Today
12:06pm, Thursday, 20'th May 2021
Looking for top penny stocks to buy under $2? Check these 3 out for some watchlist inspiration The post 3 Penny Stocks To Watch Under $2 Making Big Moves Today appeared first on Penny Stocks to Buy, P
TYME Announces Abstract Selected for Publication at the 2021 American Society of Clinical Oncology Annual Meeting
09:05am, Monday, 10'th May 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)--TYME Technologies, Inc. (Nasdaq: TYME) (the “Company” or “Tyme”), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™),
Why Tyme Stock Got Demolished Today
02:00pm, Thursday, 04'th Feb 2021
The clinical-stage biotech provides investors with a quarterly update.
TYME Stock Price Falls Over 25% Pre-Market: Why It Happened
08:21am, Thursday, 04'th Feb 2021
The stock price of Tyme Technologies Inc (NASDAQ: TYME) is trading down over 25% pre-market as of 8:15 AM ET. This is why it happened.
TYME Provides Business Update and Announces Third Quarter Fiscal 2021 Financial and Operating Results
08:00am, Thursday, 04'th Feb 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced financial and
TYME Announces $100 Million Registered Direct Offering of Common Stock Priced At-the-Market under Nasdaq Rules
01:22am, Thursday, 04'th Feb 2021
BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), today announced that it h
TYME Stock Price Increases Over 100%: Why It Happened
01:46pm, Wednesday, 03'rd Feb 2021
The stock price of Tyme Technologies Inc (NASDAQ: TYME) is trading at over 100% today. This is why it happened.
Why Tyme Technologies Stock Is Crushing It Today
12:30pm, Wednesday, 03'rd Feb 2021
The U.S. Patent and Trademark Office is on Tyme's side.
Why Tyme Technologies Shares Are Surging Higher
12:08pm, Wednesday, 03'rd Feb 2021
Tyme Technologies Inc (NASDAQ: TYME) shares are nearly doubling on above-average volume Wednesday. Tyme, which focuses on developing cancer metabolism-based therapies, said the U.S. Patent and Tradema
Revisiting Tyme Technologies
01:51am, Thursday, 17'th Dec 2020
Revisiting Tyme Technologies
TYME Announces SM-88 Abstract Selected for Presentation at the American Society of Clinical Oncology 2021 Gastrointestinal Cancers Symposium
08:00am, Wednesday, 09'th Dec 2020
BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTs™), announced that an abstra
TYME Builds Leadership Team with Announcement of New CEO
08:00am, Monday, 30'th Nov 2020
BEDMINSTER, N.J.--(BUSINESS WIRE)---- $TYME--Tyme Technologies, Inc. (NASDAQ: TYME), an emerging biotechnology company developing cancer metabolism-based therapies (CMBTsTM), announced that, effective
